Carregant...
Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner
Telomerase, the end-replication enzyme, is reactivated in malignant cancers to drive cellular immortality. While this distinction makes telomerase an attractive target for anti-cancer therapies, most approaches for inhibiting its activity have been clinically ineffective. As opposed to inhibiting te...
Guardat en:
| Publicat a: | Cell Rep |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6072277/ https://ncbi.nlm.nih.gov/pubmed/29874588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2018.05.020 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|